Laboratory Animal Welfare: Report on Reducing Administrative Burden for Researchers: Animal Care and Use in Research, 45159-45160 [2019-18611]
Download as PDF
<![CDATA[
jbell on DSK3GLQ082PROD with NOTICES
Federal Register / Vol. 84, No. 167 / Wednesday, August 28, 2019 / Notices
Health, 6701 Rockledge Drive, Room 5182,
MSC 7844, Bethesda, MD 20892, (301) 408–
9664, bishopj@csr.nih.gov.
Name of Committee: Molecular, Cellular
and Developmental Neuroscience Integrated
Review Group; Cellular and Molecular
Biology of Glia Study Section.
Date: September 26–27, 2019.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Lorien Hotel & Spa, 1600 King
Street, Alexandria, VA 22314.
Contact Person: Linda MacArthur, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4187,
Bethesda, MD 20892, 301–537–9986,
macarthurlh@csr.nih.gov.
Name of Committee: Healthcare Delivery
and Methodologies Integrated Review Group;
Community Influences on Health Behavior
Study Section.
Date: September 26–27, 2019.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Melrose Hotel, 2430 Pennsylvania
Ave. NW, Washington, DC 20037.
Contact Person: Tasmeen Weik, DRPH,
MPH, Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3141,
Bethesda, MD 20892, 301–827–6480, weikts@
mail.nih.gov.
Name of Committee: Bioengineering
Sciences & Technologies Integrated Review
Group; Biodata Management and Analysis
Study Section.
Date: September 26–27, 2019.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Embassy Suites Alexandria Old
Town, 1900 Diagonal Road, Alexandria, VA
22314.
Contact Person: Wenchi Liang, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3150,
MSC 7770, Bethesda, MD 20892, 301–435–
0681, liangw3@csr.nih.gov.
Name of Committee: Cell Biology
Integrated Review Group; Nuclear and
Cytoplasmic Structure/Function and
Dynamics Study Section.
Date: September 26, 2019.
Time: 8:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: The Allerton Hotel, 701 North
Michigan Avenue, Chicago, IL 60611.
Contact Person: Jessica Smith, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD
20892, jessica.smith6@nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; PAR18–731
Cancer Workforce Development.
Date: September 26, 2019.
Time: 12:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
VerDate Sep<11>2014
20:14 Aug 27, 2019
Jkt 247001
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892.
Contact Person: Ola Mae Zack Howard,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4192,
MSC 7806, Bethesda, MD 20892, 301–451–
4467, howardz@mail.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; PAR18–721:
Counter Act Exploratory Grants.
Date: September 27, 2019.
Time: 8:00 a.m. to 4:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hotel Monaco Baltimore, 2 N
Charles Street, Baltimore, MD 21201.
Contact Person: Geoffrey G. Schofield,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4040–A,
MSC 7850, Bethesda, MD 20892, 301–435–
1235, geoffreys@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Early Phase
Clinical Trials in Imaging and Image-Guided
Interventions (R01 Clinical Trial Required).
Date: September 27, 2019.
Time: 11:00 a.m. to 2:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive Bethesda,
MD 20892, (Virtual Meeting).
Contact Person: Ileana Hancu, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5116,
Bethesda, MD 20817, 301–402–3911,
ileana.hancu@nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel;
Cardiovascular and Respiratory Sciences,
NIH Research Enhancement Award Review.
Date: September 27, 2019.
Time: 12:30 p.m. to 3:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive Bethesda,
MD 20892, (Virtual Meeting).
Contact Person: Sara Ahlgren, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, RM 4136,
Bethesda, MD 20892, 301–435–0904,
sara.ahlgren@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: August 23, 2019.
Ronald J. Livingston, Jr.,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2019–18530 Filed 8–27–19; 8:45 am]
BILLING CODE 4140–01–P
PO 00000
Frm 00040
Fmt 4703
Sfmt 4703
45159
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Center for Complementary &
Integrative Health; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Center for
Complementary and Integrative Health
Special Emphasis Panel; Natural Products
NMR Open Data Exchange (NP–NODE U24).
Date: September 26, 2019.
Time: 5:00 p.m. to 8:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Bethesda North Marriott Hotel &
Conference Center, 5701 Marinelli Road,
Rockville, MD 20852.
Contact Person: Ashlee Tipton, Ph.D.,
Scientific Review Officer, Division of
Extramural Activities, National Center for
Complementary and Integrative Health, 6707
Democracy Boulevard, Room 401, Bethesda,
MD 20892, 301–451–3849, ashlee.tipton@
nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.213, Research and Training
in Complementary and Alternative Medicine,
National Institutes of Health, HHS)
Dated: August 23, 2019.
Ronald J. Livingston, Jr.,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2019–18533 Filed 8–27–19; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Laboratory Animal Welfare: Report on
Reducing Administrative Burden for
Researchers: Animal Care and Use in
Research
AGENCY:
National Institutes of Health,
HHS.
ACTION:
Notice.
The National Institutes of
Health (NIH) is announcing the
SUMMARY:
E:\FR\FM\28AUN1.SGM
28AUN1
45160
Federal Register / Vol. 84, No. 167 / Wednesday, August 28, 2019 / Notices
publication of Reducing Administrative
Burden for Researchers: Animal Care
and Use in Research, a report by the
NIH, the United States Department of
Agriculture (USDA), and the Food and
Drug Administration (FDA). The report
describes the recommendations of the
21st Century Cures Act, Section 2034(d),
Working Group and decisions of the
agencies.
FOR FURTHER INFORMATION CONTACT:
Patricia Brown, Office of Laboratory
Animal Welfare (OLAW), Office of
Extramural Research, National Institutes
of Health, Suite 2500, 6700B Rockledge
Drive, Bethesda, MD 20892–6910,
phone: 301–496–7163, email: olaw@
od.nih.gov.
SUPPLEMENTARY INFORMATION:
jbell on DSK3GLQ082PROD with NOTICES
I. Background
Title II, Section 2034(d) of the 21st
Century Cures Act (Pub. L. 114–255)
was enacted December 13, 2016, and
requires the NIH in collaboration with
USDA and FDA to complete a review of
applicable regulations and policies for
the care and use of laboratory animals
and to make revisions, as appropriate, to
reduce administrative burden on
investigators while maintaining the
integrity and credibility of research
findings and protection of research
animals. The Act instructs NIH to: (1)
Seek the input of experts, if appropriate;
(2) identify ways to ensure applicable
regulations and policies are not
inconsistent, overlapping, or
unnecessarily duplicative; (3) take steps
to eliminate or reduce identified
inconsistencies, overlap, or duplication
among such regulations and policies;
and (4) take other actions, as
appropriate, to improve the
coordination of regulations and policies
with respect to research with laboratory
animals.
NIH, USDA, and FDA convened a
Working Group of federal subject matter
experts to identify inconsistent,
overlapping, and unnecessarily
duplicative regulations and policies and
prepare a report of their
recommendations as directed in the 21st
Century Cures Act. The report on
Reducing Administrative Burden for
Researchers: Animal Care and Use in
Research describes the efforts of the
Working Group, their recommendations,
and the decisions of NIH, USDA, and
FDA on the recommendations.
II. Electronic Access
The report on Reducing
Administrative Burden for Researchers:
Animal Care and Use in Research is
available at https://olaw.nih.gov/sites/
default/files/21CCA_final_report.pdf.
VerDate Sep<11>2014
20:14 Aug 27, 2019
Jkt 247001
Dated: August 21, 2019.
Francis S. Collins,
Director, National Institutes of Health.
[FR Doc. 2019–18611 Filed 8–27–19; 8:45 am]
DEPARTMENT OF HOMELAND
SECURITY
Federal Emergency Management
Agency
BILLING CODE 4140–01–P
[Docket ID FEMA–2019–0002]
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Center for Complementary &
Integrative Health; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Center for
Complementary and Integrative Health
Special Emphasis Panel; Botanical Dietary
Supplements Research Centers (BDSRC U19).
Date: September 25–26, 2019.
Time: September 25, 2019, 8:00 a.m. to
3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Bethesda North Marriott Hotel &
Conference Center, 5701 Marinelli Road,
Rockville, MD 20852.
Contact Person: Ashlee Tipton, Ph.D.,
Scientific Review Officer, Division of
Extramural Activities, National Center for
Complementary and Integrative Health, 6707
Democracy Boulevard, Room 401, Bethesda,
MD 20892, 301–451–3849, ashlee.tipton@
nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.213, Research and Training
in Complementary and Alternative Medicine,
National Institutes of Health, HHS)
Dated: August 23, 2019.
Ronald J. Livingston, Jr.,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2019–18539 Filed 8–27–19; 8:45 am]
BILLING CODE 4140–01–P
PO 00000
Frm 00041
Fmt 4703
Sfmt 4703
Final Flood Hazard Determinations
Federal Emergency
Management Agency, DHS.
ACTION: Notice.
AGENCY:
Flood hazard determinations,
which may include additions or
modifications of Base Flood Elevations
(BFEs), base flood depths, Special Flood
Hazard Area (SFHA) boundaries or zone
designations, or regulatory floodways on
the Flood Insurance Rate Maps (FIRMs)
and where applicable, in the supporting
Flood Insurance Study (FIS) reports
have been made final for the
communities listed in the table below.
The FIRM and FIS report are the basis
of the floodplain management measures
that a community is required either to
adopt or to show evidence of having in
effect in order to qualify or remain
qualified for participation in the Federal
Emergency Management Agency’s
(FEMA’s) National Flood Insurance
Program (NFIP). In addition, the FIRM
and FIS report are used by insurance
agents and others to calculate
appropriate flood insurance premium
rates for buildings and the contents of
those buildings.
DATES: The date of December 6, 2019
has been established for the FIRM and,
where applicable, the supporting FIS
report showing the new or modified
flood hazard information for each
community.
ADDRESSES: The FIRM, and if
applicable, the FIS report containing the
final flood hazard information for each
community is available for inspection at
the respective Community Map
Repository address listed in the tables
below and will be available online
through the FEMA Map Service Center
at https://msc.fema.gov by the date
indicated above.
FOR FURTHER INFORMATION CONTACT: Rick
Sacbibit, Chief, Engineering Services
Branch, Federal Insurance and
Mitigation Administration, FEMA, 400
C Street SW, Washington, DC 20472,
(202) 646–7659, or (email)
patrick.sacbibit@fema.dhs.gov; or visit
the FEMA Map Information eXchange
(FMIX) online at https://
www.floodmaps.fema.gov/fhm/fmx_
main.html.
SUPPLEMENTARY INFORMATION: The
Federal Emergency Management Agency
(FEMA) makes the final determinations
SUMMARY:
E:\FR\FM\28AUN1.SGM
28AUN1
]]>Agencies
[Federal Register Volume 84, Number 167 (Wednesday, August 28, 2019)]
[Notices]
[Pages 45159-45160]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-18611]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Laboratory Animal Welfare: Report on Reducing Administrative
Burden for Researchers: Animal Care and Use in Research
AGENCY: National Institutes of Health, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The National Institutes of Health (NIH) is announcing the
[[Page 45160]]
publication of Reducing Administrative Burden for Researchers: Animal
Care and Use in Research, a report by the NIH, the United States
Department of Agriculture (USDA), and the Food and Drug Administration
(FDA). The report describes the recommendations of the 21st Century
Cures Act, Section 2034(d), Working Group and decisions of the
agencies.
FOR FURTHER INFORMATION CONTACT: Patricia Brown, Office of Laboratory
Animal Welfare (OLAW), Office of Extramural Research, National
Institutes of Health, Suite 2500, 6700B Rockledge Drive, Bethesda, MD
20892-6910, phone: 301-496-7163, email: [email protected].
SUPPLEMENTARY INFORMATION:
I. Background
Title II, Section 2034(d) of the 21st Century Cures Act (Pub. L.
114-255) was enacted December 13, 2016, and requires the NIH in
collaboration with USDA and FDA to complete a review of applicable
regulations and policies for the care and use of laboratory animals and
to make revisions, as appropriate, to reduce administrative burden on
investigators while maintaining the integrity and credibility of
research findings and protection of research animals. The Act instructs
NIH to: (1) Seek the input of experts, if appropriate; (2) identify
ways to ensure applicable regulations and policies are not
inconsistent, overlapping, or unnecessarily duplicative; (3) take steps
to eliminate or reduce identified inconsistencies, overlap, or
duplication among such regulations and policies; and (4) take other
actions, as appropriate, to improve the coordination of regulations and
policies with respect to research with laboratory animals.
NIH, USDA, and FDA convened a Working Group of federal subject
matter experts to identify inconsistent, overlapping, and unnecessarily
duplicative regulations and policies and prepare a report of their
recommendations as directed in the 21st Century Cures Act. The report
on Reducing Administrative Burden for Researchers: Animal Care and Use
in Research describes the efforts of the Working Group, their
recommendations, and the decisions of NIH, USDA, and FDA on the
recommendations.
II. Electronic Access
The report on Reducing Administrative Burden for Researchers:
Animal Care and Use in Research is available at https://olaw.nih.gov/sites/default/files/21CCA_final_report.pdf.
Dated: August 21, 2019.
Francis S. Collins,
Director, National Institutes of Health.
[FR Doc. 2019-18611 Filed 8-27-19; 8:45 am]
BILLING CODE 4140-01-P
